Aspen Surgical Products, Inc. (“Aspen”) announces that it has acquired the Bard-Parker™ surgical blades and scalpels business from BD (Becton, Dickinson and Company). Aspen is a leading manufacturer of disposable medical products with an emphasis on the operating room environment and safety. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems, and reagents.
Bard-Parker™ is a widely recognized brand in the operating room with leadership positions in both the U.S. and Canada. It joins Aspen’s other successful products including surgical needles and skin markers, disposable light handles, instrument guards, anti-fog solutions, and fluid management products. Aspen sells these products under the brand names Richard-Allan, Dr. Fog®, Sterion®, Colby, Steriseal®, and Oxboro®.
“Bard-Parker™ is a well respected brand with trusted results in the field”, said Terry O’Rourke, President of Aspen. “The acquisition of Bard-Parker™ will create great opportunities with our existing portfolio of brands.”
As part of the transaction, Aspen acquired a state-of-the-art facility in Las Piedras, Puerto Rico dedicated to the manufacturing of the Bard-Parker™ line. Aspen manufactures its other products in facilities in Grand Rapids, MI and Redditch, England.
“The acquisition of the Bard-ParkerTM brand of surgical blades and scalpels further positions Aspen as a leading provider of patient and staff safety products in the operating room,” said Greg Pritchard, CEO of Aspen. “The Bard-ParkerTM products have a one-hundred year history, considerable performance benefits, and advanced safety features that will allow Aspen to participate to a greater degree in this high growth segment of the market.”
For more information, visit www.aspensurgical.com